Federico Mingozzi

Federico Mingozzi

Director/Board Member at SENSORION
52 year
Health Technology
Consumer Services
Commercial Services

Profile

Federico Mingozzi is currently President & Chief Executive Officer at Nava Therapeutics, Inc., Director & Treasurer at the American Society of Gene & Cell Therapy, and Non-Executive Director at Sensorion SA since 2024.
Formerly, Dr. Mingozzi was Research Director at Institut National de la Santé & de la Recherche Médicale from 2016 to 2017, Chief Science & Technology Officer at Spark Therapeutics, Inc. from 2017 to 2023, and Head-Immunology & Liver Gene Transfer at Genethon from 2013 to 2017.
Education includes an MBA from Drexel University and a doctorate from the University of Ferrara.

Federico Mingozzi active positions

CompaniesPositionStart
SENSORION Director/Board Member 2024-01-23
Director/Board Member -

Former positions of Federico Mingozzi

CompaniesPositionEnd
SPARK THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2023-10-31
Chief Tech/Sci/R&D Officer 2017-08-31
Corporate Officer/Principal 2017-08-31
See the detail of Federico Mingozzi's experience

Training of Federico Mingozzi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

19

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Federico Mingozzi